News & Events :: SCYNEXIS, Inc. (SCYX)

Skip to main content Skip to section navigation Skip to footer

Recent News

Jan 28, 2026 8:00am EST

SCYNEXIS Announces Presentations Highlighting the Potent Antifungal Activity of its Second-Generation Fungerp, SCY-247 Against Drug-Resistant Fungi, at the Inaugural Interdisciplinary Meeting on Antimicrobial Resistance and Innovation (IMARI)

Jan 21, 2026 8:00am EST

SCYNEXIS Receives FDA Qualified Infectious Disease Product (QIDP) and Fast Track Designations for SCY-247

Recent Events

View All Events

Jan 28 – Jan 30, 2026

Interdisciplinary Meeting on Antimicrobial Resistance and Innovation

View All Events

Latest Presentation

View All Presentations

Nov 6, 2025

Investor Presentation

View All Presentations

Email Alerts

Sign up for email alerts for Press Releases & SEC Filings